Aktie A3CMVF CM LIFE SCIENCES III INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CM Life Sciences III Inc. Nasdaq

Aktien

A3CMVF

US1258412055

CMLTU

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
CM Life Sciences III : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company
CM Life Sciences III : Submission of Matters to a Vote of Security Holders - Form 8-K
CM LIFE SCIENCES III INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.
EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
CM LIFE SCIENCES III INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa
EQRx Launches “Remaking Medicine: On The Record” Investor Video Series
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
CM LIFE SCIENCES III INC. : Entry into a Material Definitive Agreement (form 8-K)
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines
EQRx : and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021.
EQRx : Appoints Kathy Giusti to Board of Directors
EQRx : Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CS53 Aktie
  4. A3CMVF Aktie
  5. Nachrichten CM Life Sciences III Inc.
  6. Andere Sprachen